Everything you need to know about semaglutide, tirzepatide, Ozempic, Wegovy, and Mounjaro — including cost, eligibility, and how to get a prescription online.
⚕️ Educational content only. Not medical advice. Consult a licensed provider.
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of injectable or oral medications that mimic a naturally occurring gut hormone. Originally developed to treat type 2 diabetes, they have revolutionized weight management after clinical trials demonstrated unprecedented weight loss results.
These medications work by signalling the brain that you're full (reducing appetite), slowing how fast food leaves your stomach (reducing caloric intake), and improving insulin sensitivity. The result is sustainable, medically supervised weight loss without the need for surgery.
Compare the main options prescribed by licensed telehealth providers.
Fill out a 5-minute health questionnaire covering your BMI, medical history, and weight loss goals.
A licensed Canadian physician reviews your information and determines if GLP-1 therapy is appropriate for you.
If approved, your prescription is sent to a compounding or retail pharmacy. Most medications ship within 3–5 days.
Use GLP Metrics dashboard to log your doses, track weight loss, and monitor your symptom forecast week by week.
In Canada, GLP-1 medications are typically approved for adults who meet one of the following criteria:
Prices vary depending on whether you use insurance, a retail pharmacy, or a compounding pharmacy through a telehealth provider.
| Medication | Retail (no insurance) | Telehealth Cash-Pay | With Insurance |
|---|---|---|---|
| Ozempic (semaglutide) | $280–$420/mo | $199–$299/mo | Often covered (T2D) |
| Wegovy (semaglutide 2.4mg) | $400–$550/mo | $249–$349/mo | Limited coverage |
| Mounjaro (tirzepatide) | $430–$590/mo | $299–$399/mo | Limited coverage |
| Saxenda (liraglutide) | $320–$450/mo | $199–$280/mo | Varies by plan |
* Prices are estimates based on publicly available telehealth provider pricing as of 2025. Actual costs may vary. Always verify with your provider.
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a natural gut hormone to reduce appetite, slow gastric emptying, and lower blood sugar. They are FDA-approved for weight management and type 2 diabetes.
Through a licensed telehealth provider, you complete an online intake form, a physician reviews your medical history, and if appropriate, issues a prescription. Most platforms ship directly to your door within 3–7 business days.
Clinical trials show tirzepatide achieves slightly higher average weight loss (~20–22% body weight) compared to semaglutide (~15%). However, individual results vary. The best medication depends on your health profile, which your provider will assess.
Coverage varies by province and plan. Ozempic is commonly covered for type 2 diabetes management. Wegovy (weight management indication) has more limited coverage. Many telehealth platforms offer transparent cash-pay pricing.
The most common side effects are nausea, vomiting, diarrhea, and constipation, particularly in the first 4–8 weeks as your dose is titrated up. These typically improve over time. Serious side effects are rare but include pancreatitis.
Most people experience appetite suppression within 1–2 weeks. Significant weight loss (5–10% of body weight) is typically observed by weeks 4–8, with maximum effect at 68 weeks according to STEP trial data.
Take our free 90-second eligibility quiz and get matched with a licensed United States provider.
Start Free Quiz →⚕️ This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any treatment.